- Title
- MAIT cell activation augments adenovirus vector vaccine immunogenicity
- Creators
- Nicholas M Provine - Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UKA Amini - Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UKLucy C Garner - Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UKAlexandra J Spencer - Jenner Institute, University of Oxford, Oxford, UKChristina Dold - Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UKClaire Hutchings - Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UKLaura Silva-Reyes - Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UKMichael E. B FitzPatrick - Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UKSenthil Chinnakannan - Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UKBlanche Oguti - Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UKMeriel Raymond - Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UKMarta Ulaszewska - Jenner Institute, University of Oxford, Oxford, UKFulvia Troise - Nouscom, SRL, Rome, Italy., Ceinge Biotechnologie Avanzate, Naples, ItalyHannah Sharpe - Jenner Institute, University of Oxford, Oxford, UKSophie B Morgan - Respiratory Medicine Unit, Nuffield Department of Medicine – Experimental Medicine, University of Oxford, Oxford, UKTimothy S. C Hinks - Respiratory Medicine Unit, Nuffield Department of Medicine – Experimental Medicine, University of Oxford, Oxford, UKTeresa Lambe - Jenner Institute, University of Oxford, Oxford, UKStefania Capone - ReiThera, SRL, Rome, ItalyAntonella Folgori - ReiThera, SRL, Rome, ItalyE Barnes - Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jenner Institute, University of Oxford, Oxford, UK., Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UKCHRISTINE ROLLIERAndrew J. Pollard - Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, UKPaul Klenerman - Translational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK
- Publication Details
- Science (American Association for the Advancement of Science), Vol.371(6528), pp.521-526
- Date published
- 29/01/2021
- Identifiers
- 99618165502346
- Academic Unit
- School of Biosciences
- Language
- English
- Resource Type
- Journal article
Journal article
MAIT cell activation augments adenovirus vector vaccine immunogenicity
Science (American Association for the Advancement of Science), Vol.371(6528), pp.521-526
29/01/2021
PMID: 33510029
Metrics
74 Record Views